Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025

– Two poster presentations will highlight research on the effects of paracentesis and CKD in adults with HRS-AKI1,2 – DUBLIN, Oct. 30, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in...